Gapping up
In reaction to strong earnings/guidance: BGFV +6.8%, INFY +5.7%, MTN +3.3%, (Season-to-date lift ticket rev +19.4%; expects to exceed EBITDA guidance ), JPM +1.8%, CLC +1.6%, WNS +1.1%, BCE +0.5%
M&A news: WBMD +7.1% (in talks with a number of potential buyers over parts or all of its business, according to the FT), FORTY +2.9% (Formula Systems and Israel Aerospace Industries acquire military unit of Ness Tech (NSTC) for $50 mln)
Select financial related names showing strength after JPM earnings: MS +1.6%, C +0.8%, BAC +0.7%
Select metals/mining stocks trading higher: HMY +3.9%, BBL +2.4%, VALE +2.2%, BHP +1.8%, RIO +1.5%
Select oil/gas related names showing strength: EPE +5.8%, SN +3.9%, TOT +2.7%, BP +2.3%, OAS +2%, COG+1.8%, RDS.A +1.2%, CHK +1.1%
Other news: IPCI +11.8% (announces successful bioequivalence results for abuse deterrent Rexista Oxycodone XR),MNKD +5.1% (cont pre-mkt volatility), ERIC +2.4% (extends patent cross license agreement with Huawei)
Analyst comments: TRGP +5.3% (upgraded to Buy from Hold at Jefferies), CMG +1.8% (upgraded to Buy from Outperform at Credit Agricole)
In reaction to strong earnings/guidance: BGFV +6.8%, INFY +5.7%, MTN +3.3%, (Season-to-date lift ticket rev +19.4%; expects to exceed EBITDA guidance ), JPM +1.8%, CLC +1.6%, WNS +1.1%, BCE +0.5%
M&A news: WBMD +7.1% (in talks with a number of potential buyers over parts or all of its business, according to the FT), FORTY +2.9% (Formula Systems and Israel Aerospace Industries acquire military unit of Ness Tech (NSTC) for $50 mln)
Select financial related names showing strength after JPM earnings: MS +1.6%, C +0.8%, BAC +0.7%
Select metals/mining stocks trading higher: HMY +3.9%, BBL +2.4%, VALE +2.2%, BHP +1.8%, RIO +1.5%
Select oil/gas related names showing strength: EPE +5.8%, SN +3.9%, TOT +2.7%, BP +2.3%, OAS +2%, COG+1.8%, RDS.A +1.2%, CHK +1.1%
Other news: IPCI +11.8% (announces successful bioequivalence results for abuse deterrent Rexista Oxycodone XR),MNKD +5.1% (cont pre-mkt volatility), ERIC +2.4% (extends patent cross license agreement with Huawei)
Analyst comments: TRGP +5.3% (upgraded to Buy from Hold at Jefferies), CMG +1.8% (upgraded to Buy from Outperform at Credit Agricole)